Project Grant R15HL173852
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$429K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Houghton, MI, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $293,653 to 3DT Holdings, LLC to develop a software tool for optimizing cardiac resynchronization therapy (CRT), conduction system pacing (CSP), and left ventricular endocardial pacing (LVEP) therapies. The goal is to reduce non-responder rates and improve patient identification for these treatments, especially for patients with...
The federal Project Grant award R21HL172209, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to apply machine learning techniques to analyze longitudinal changes in electrocardiogram (ECG) data for individuals with congenital heart disease. The $117,375 award, effective from August 1, 2024 to July 31, 2026, aims to identify ECG biomarkers that can predict the need for cardiac intervention or...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2,027,737 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to 3DT Holdings, LLC, a minority-owned biomedical engineering company. The objective of this "fast-track" proposal is to develop and validate a machine learning (ML)-based software tool for optimizing MitraClip placement procedures and predicting key outcomes like mitral regurgitation, left atrial pressure, and cardiac tissue...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $298,368 Project Grant to Link Medical LLC in Chelsea, Michigan. The funding supports the development of a novel catheter-based device for treating mitral valve regurgitation, a prevalent cardiovascular condition expected to impact over 4 million Americans by 2030. The project aims to optimize the device design and procedural details through bench testing, followed...
This Project Grant award of $752,495 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop a deep learning-based method to remove cardiopulmonary resuscitation (CPR) artifacts from electrocardiogram (ECG) signals during out-of-hospital cardiac arrest. The University of Connecticut will create a database of CPR-contaminated ECG data, evaluate and optimize a deep learning CPR artifact removal algorithm, and integrate the validated...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $299,604 to Case Western Reserve University to develop and validate a novel transfer volume regression model. This model aims to enable quantitative clinical risk predictions for major cardiovascular events, including stroke, heart attack, heart failure, and death. The project will leverage commonly used, low-cost screening programs to...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $167,588 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant, awarded on March 1, 2025, with a completion date of February 28, 2030, will support the career development of Dr. Son Duong, a clinician-scientist specializing in pediatric cardiology and advanced cardiovascular imaging. The primary objectives are to: 1) Develop and validate a...
This Project Grant award of $194,400 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a multilevel implementation intervention to equitably prescribe evidence-based therapy for hospitalized heart failure patients. The key products or services to be delivered through this funding include: Assessing multilevel variation in equitable guideline-directed medical therapy (GDMT) prescribing during...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $691,326 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Northwestern University to develop a "4D Right-Heart Virtual Catheter (4D VCATH)". This novel technology combines advanced mathematical modeling and 4D flow MRI to provide a comprehensive, non-invasive hemodynamic analysis of the right heart chambers. The project aims to enable streamlined diagnosis, classification, and prognosis...
This federal Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $439,954 to Michigan State University (MSU) to develop advanced computational models of the heart that leverage machine learning and artificial intelligence. The goal is to create a multiscale modeling framework that can predict structural and functional changes in the heart due to disease conditions like pathological fibrosis. The...